George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Still here . Not one share sold. Sadly no funds available to buy a meaningful extra amount.
As I understand it Numis predictions were allowing for a vaccine to be available.
Too much emphasis on covid and not on enough on copd and a host of other respiratory conditions which is really what the company is all about.
A successful therapy for for these is arguably more valuable financially than just dealing with one strain of virus although in human terms what Synairgen is doing is absolutely right.
Covid and sng001 will hopefully add another string to an already very well strung bow.
1) Preference - Full takeover. ( Any large Pharma )
2) Target - Minimum share price £12. ( Hopefully very conservative )
3) Timeframe - 15 months max. ( Hopefully much sooner )
The above will allow me to offer my children some financial security, a move of house as well as rewarding myself with a little " fun money. "
We will all have our own individual preferences depending on our personal situations and it would be interesting to hear what other people would like to see happen in terms of monetary reward and time frames.
The million pounds spent was just his fee he demanded from Sky.
Happyhippostew
You may have sorted it out but if it helps I received an e- mail from II.
Log in go to portfolio then corporate actions and the instructions should be there.
Good luck.
We need clarity. We have simply been allocated a number of shares so we should be able to choose ISA/non ISA mix subject to ISA limits.
What difference does it make to SNG or anyone else ?
Maybe posted already but surely the timing of the RNS cannot be co-incidental.
Something else to factor into everything that is expected to unfurl tomorrow.
Quite a momentous day to come I think!
HarChris
No, just observing for the purposes of scientific research !
I will not be posting for a couple of days. Around at Woodstock's house for the weekend.
A healthy rise in the s.p. is:
Better than alcohol
Better than any white powder
Better than sex ----- well almost !
and don't forget there are only 149m shares in issue.
Feels like we are members of an exclusive club.
GLA
CityTTrader
All I can go on is that in a pre- COVID interview R.M. stated that the market for the treatment of COPD was worth "billions" worldwide.
COPD will be around for decades to come, COVID hopefully much less so.
With everything in sng's locker including Loxl 2 then being a major player in therapeutic treatments for a whole host of medical conditions firmly places the company's potential .
valuation as "off the scale"
Things most definitely coming together now.
Always remember COVID is a last minute ordered side dish. COPD is the main course.
As has been said the content, detail and the quality of some of the posts on this board has been remarkable and obviously quite time consuming to research.
We are concerned that all the positives of SNG001 are falling on too many deaf ears but I am sure not those of the major Pharmas.
They must employ people to seek out every available statistic and piece of research world wide to help them with their decision making re a possible J/V or a T/O.
So I would assume that once the all important approval is given their intentions will already have been decided.
It could be, of course, that a major pharma is already lined up just waiting for starting gun to be fired.
GLA
Put yourself in the position of those involved at sng.
Some will consider their lifetime scientific work is almost done and relish a very comfortable retirement.
Others may welcome the opportunity to set up a new company to embark on a new programme of research on other health conditions linked to their area of expertise. They would also be well funded from their own funds to get the company off the ground.
For these reasons I would suggest that a T/O would be their preferred choice.
It certainly would be mine at the right price.
It seems to me that if, as is highly likely, MM's are manipulating the s.p. downwards then to maximise their returns they must propel the s.p. upwards again at some point, after they have " harvested" the shares of panicked PI's and ill judged stop losses.
The irrationally low s.p.' attracts higher volumes of business from those more astute investors who recognise that whatever the dip, the fundamentals and the potential remain as before.
GLA
This is our favourite share and MM's favourite toy.
If the Government is going to continue fanny*ing around seemingly ignoring all the positives re SNG001 then R.M. will simply see his company in the hands of the American Pharmas and guess who will claim the credit !
The main priority here is to get this drug on the market and start saving lives. I sincerely hope that the R.N.S. we are all looking forward to arrives very soon and quite honestly I am now beyond caring into whose hands this wonderful drug developed and refined over 15 years by a dedicated , talented and very professional team of British scientists eventually finishes up as long as they, ourselves and the world in general all benefit either financially or with much improved health outcomes.
I just wonder how R.M. really feels at the moment.
There are several MM's { banks, brokers etc ) so who decides on the price and with reference to this evenings nonsense surely they would all have to be in agreement.
Somebody suggested "mates rates" but that can only apply to one MM I would assume.
Please excuse my ignorance , I am sure the more knowledgeable among you will have a simple answer.
Still convinced that Synairgen's future is firmly in the hands of American pharmas , hence no mention.
Congratulations Mr. & Mrs. Ghia on your new arrival.
Look forward to your posts at 1.30 a.m. 2.30a.m.3.30 a.m.4.30a.m. ---- !